By Peter A. McCullough, MD, MPH
In this powerful and wide-ranging interview on the Get Better Faster podcast, summarized by AlterAI, hosts Dr. Jason Bradley and James Chester welcome Dr. Peter McCullough — cardiologist, internist, epidemiologist, and one of the most prominent voices of dissent during the COVID-19 era. The conversation explores his early warnings about vaccine safety, the development of his spike protein detoxification protocol, and his reflections on systemic failures within modern medicine. McCullough speaks with the conviction of a man who challenged entrenched power and paid a professional price for refusing to be silent when the official narrative turned dogmatic.
From the outset, Dr. Bradley highlights McCullough’s credentials and courage: over a thousand peer-reviewed publications, testimony before U.S. and European legislatures, and his role in developing an early outpatient treatment protocol for COVID-19. When the pandemic began, McCullough immediately recognized what he called “the great gamble of the COVID-19 vaccine development program.” He warned in an August 2020 The Hill op-ed that using genetic code to instruct human cells to manufacture a viral spike protein — the component responsible for the virus’s infectivity — could have disastrous consequences. He called it “the worst idea ever,” a prediction that he says has been vindicated by the post-vaccination myocardial inflammation now officially warned about by the FDA.
McCullough recounts how his early calls for caution and his Senate testimony on outpatient COVID treatment were aggressively censored. His hearings were removed from C-SPAN and social media platforms “wiped them off the map.” Only years later, in 2025, were these testimonies restored to public view. He recalls trying to remain neutral when the vaccines were released in December 2020, advising patients simply, “I don’t know.” But by March 2021, after hundreds of early reports of post-vaccination deaths and escalating concerns about myocarditis, he publicly sounded alarms in the Texas Senate — prompting a fierce professional backlash that cost him credentials and positions.
The discussion turns to the biology of mRNA technology. McCullough contrasts traditional vaccines — live attenuated or protein-based — with the synthetic messenger RNA encapsulated in lipid nanoparticles that drive internal cellular production of spike protein. Because this pseudouridinated mRNA “cannot be broken down,” he argues, the body effectively becomes a chronic spike factory, leading to inflammation and vascular injury. He insists that spike persistence has now been measured years after injection in some individuals, illustrating why post-vaccine syndromes remain unresolved for so many.
For those seeking context on differing vaccine platforms, McCullough explains that the Johnson & Johnson product uses an adenovirus vector — still a gene-based delivery system, but one that does not persist indefinitely. Roughly 5% of vaccinated Americans chose this option. He notes that Novavax, containing purified spike protein rather than gene material, would have been the “least risky” and laments that it was barely promoted. He estimates that about 2% of vaccine recipients suffered measurable heart damage, citing both independent and Pfizer-funded studies, and warns of accumulating evidence — including autopsy data from Japan — showing microscopic scarring in cardiac tissue after multiple doses.
The hosts raise widespread public reports of young athletes dying suddenly. McCullough cautiously agrees it is a legitimate worry and urges families of sudden-death victims to insist on testing heart tissue for spike protein and mRNA fragments to confirm potential causal links. He remarks that the combination of prior vaccination and later infection may provoke a “fulminant myocarditis,” and that he still sees severe heart failure cases fitting that pattern.
James Chester brings up another controversial issue: “vaccine shedding.” McCullough acknowledges that while definitive proof of transmissible spike protein is lacking, there is reason to believe temporary shedding — particularly in the months following vaccination — could raise antibody levels in close contacts. He cites French researcher Dr. Hélène Banoun’s work on the topic, concluding that “people should use caution and safe practices.”
The conversation transitions to solutions — the realm where McCullough has drawn significant global attention. He describes how he turned from prescription drugs to natural proteolytic compounds capable of breaking down the spike protein: nattokinase, bromelain, and curcumin. Citing data showing these enzymes degrade spike protein in laboratory models and improve patient outcomes, he developed what became the McCullough Protocol Base Spike Detox—marketed through The Wellness Company as the Ultimate Spike Detox. The regimen, typically two capsules twice daily, aims to lower spike antibody titers over a year of use and relieve symptoms of long COVID and post-vaccine injury such as neuropathy, fatigue, and clotting disorders. He emphasizes that suppression of these very compounds by search engines and regulators reinforced his belief that the protocol struck a nerve with powerful interests.
When pressed on why even vitamin D and simple therapies like nasal sprays were censored, McCullough argues that during the pandemic anything that worked but threatened pharmaceutical profits was targeted. Vitamin D, he says, had multiple positive trials, yet the FTC attacked supplement companies promoting it. Similarly, saline and iodine nasal sprays were suppressed despite evidence for antiviral benefit — actions he denounces as emblematic of “regulatory capture.”
Looking forward, McCullough discusses rebuilding medicine under the new U.S. administration. True reform, he insists, requires direct “Bethesda-style meetings” among top medical leaders to dissect what went wrong: censorship of early treatment, inflating of vaccine efficacy claims, and fear-driven compliance. He emphasizes the need to restore intellectual courage among physicians, arguing that most failed the moral test of the pandemic out of fear—fear amplified by manipulated media narratives.
The final portion of the dialogue touches on future health threats, including laboratory-origin pathogens. McCullough warns that gain-of-function research is essentially “weaponization” of viruses and calls for closure of U.S. biosecurity labs, many of which he describes as insecure. As preventive advice, he reiterates daily nasal and oral antiviral hygiene — particularly Immune Defense — as the most practical defense against airborne viruses.
The episode ends on a note of empowerment. McCullough’s message is unwavering: people must take personal responsibility for health, question institutional messaging, and embrace evidence-based, low-cost prevention. His work, he concludes, has been about restoring medicine’s soul — one patient, and one act of truth, at a time.
Please subscribe to FOCAL POINTS as a paying ($5 monthly) or founder member so we can continue to bring you the truth.
Peter A. McCullough, MD, MPH
Chief Scientific Officer, The Wellness Company
